Concepedia
Statistics
Publications
8
Citations
1.8K
H-Index
Active since
1998
Affiliations
Bayer (United States)(Current)
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Icahn School of Medicine at Mount Sinai
Institució Catalana de Recerca i Estudis Avançats
Michael Shan is an author at Bayer (United States) specializing in pharmacotherapy, medicine, and antimicrobial pharmacotherapy.
Publications per year
1998–2012
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix, Jean‐Luc Raoul, Morris Sherman et al. · Journal of Hepatology · 2012 · 821 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet, Carol E. Peña, Chetan Lathia et al. · Clinical Cancer Research · 2012 · 561 citations · Full text
Medicine, Oncology, Pharmacology +14
A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women
James McCarty, G. Richard, W Huck et al. · The American Journal of Medicine · 1999 · 169 citations
Medicine, Infectious Diseases, Pharmacology +11
Randomized, Double‐Blind Study of Ciprofloxacin and Cefuroxime Axetil for Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis
Sanford Chodosh, James McCarty, Stephen A. Farkas et al. · Clinical Infectious Diseases · 1998 · 85 citations
Pharmacy, Infectious Diseases, Pharmacotherapy +14
Optimal and minimax three-stage designs for phase II oncology clinical trials
Kun Chen, Michael Shan · Contemporary Clinical Trials · 2007 · 38 citations
Medicine, Biostatistics, Oncology +7
1–5 of 8